This inventor holds 1 USPTO granted patent. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: The Innovations of Shinichi Akiyama
Introduction
Shinichi Akiyama is a notable inventor based in Kagoshima, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Shinichi Akiyama holds a patent for monoclonal antibodies. This patent represents a crucial advancement in the treatment and diagnosis of diseases, highlighting his role in the ongoing evolution of medical science. He has 1 patent to his name, reflecting his focused contributions to this specialized area.
Career Highlights
Akiyama is currently employed at Taiho Pharmaceutical Company Limited, where he continues to engage in groundbreaking research. His work at Taiho Pharmaceutical has positioned him as a key player in the pharmaceutical industry, contributing to the development of innovative therapies.
Collaborations
Throughout his career, Akiyama has collaborated with esteemed colleagues such as Kazutaka Miyadera and Yuji Yamada. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in their field.
Conclusion
Shinichi Akiyama's contributions to the field of biotechnology, particularly through his patent on monoclonal antibodies, underscore the vital role of inventors in advancing medical science. His work at Taiho Pharmaceutical Company Limited and collaborations with other professionals further exemplify the importance of teamwork in innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
